EUVIMEDEUVIMED entdecken
Crossref

Molecular Analysis of Genes CEBPA, NPM1 , IDH1 , and RUNX1 Polymorphisms as Biomarker Potential in Leukemia Patients

Kashif Bashir iD, Sadia Abdul Ghafar, Afifa Tur Rehman, Tayyaba Waris, Fatima Farooq, Amin A Alamin

Molecular Carcinogenesis · 2025-02 · 64 (2) · 357-368

DOI: 10.1002/mc.23846 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Carcinogenesis, online erschienen am 20.11.2024. Verfasst von Kashif Bashir und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, Superior University Lahore, Sargodha, Punjab, Pakistan. Hauptthemen laut MEDLINE: Polymorphism, Single Nucleotide, Core Binding Factor Alpha 2 Subunit, CCAAT-Enhancer-Binding Proteins, Isocitrate Dehydrogenase. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: The authors received no specific funding for this work..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Leukemia is found in approximately 2.3 million people worldwide and causes many deaths all over the world. This research study was conducted to figure out the link of single nucleotide polymorphisms of genes CEBPA (rs34529039), NPM1 (rs753788683), IDH1 (of rs11554137) and RUNX1 (rs13051066) polymorphisms as biomarker potential in leukemia patients. A total of 600 subjects were included in the study which included 300 patients and 300 healthy controls with age and gender matched. After DNA extraction, PCR was carried out to analyze polymorphisms of selected genes. A significant association with increased risk of leukemia by almost twofolds is observed in homozygous mutant (AA) of rs34529039 SNP of gene CEBPA (odds ratio [OR] = 1.71; 95% confidence interval [CI] = 1.04–2.82; p = 0.03) while highly significant association but with decrease risk of leukemia is observed in heterozygote genotype (CA) of same SNP (OR = 0.36; 95% CI = 0.22–0.59; p = 0.0001). A highly significant association with increased risk of leukemia up to twofolds is observed in heterozygote genotype (AG) of rs753788683 of gene NPM1 (OR 2.10: 95% CI 1.32–3.36 p = 0.0017) while increasing risk by two‐fold and show significant association in homozygous mutant (AA) (OR = 1.75; 95% Cl = 1.09–2.79; p = 0.01). Leukemia risk increases by twofold and shows significant association in the homozygous mutant (AA) of rs11554137 (OR = 1.75; 95%Cl = 1.09–2.79; p = 0.01). Leukemia risk increases by twofold and shows significant association in the homozygous mutant (AA) of rs13051066 of gene RUNX1 (OR = 0.63; 95%Cl = 0.39–1.63; p = 0.06).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polymorphism, Single NucleotideCore Binding Factor Alpha 2 SubunitCCAAT-Enhancer-Binding ProteinsIsocitrate DehydrogenaseNuclear ProteinsBiomarkers, TumorLeukemiaHumansNucleophosminMaleFemaleMiddle AgedCase-Control StudiesAdultGenetic Predisposition to DiseaseAgedYoung AdultGenotypeAdolescent

Stichwörter der Autor:innen

CEBPAIDH1, and RUNX1 genesNPM1Pakistanbiomarker potentialleukemiapolymorphisms

Substanzen

NucleophosminNPM1 protein, humanIDH1 protein, humanCore Binding Factor Alpha 2 SubunitCCAAT-Enhancer-Binding ProteinsCEBPA protein, humanIsocitrate DehydrogenaseNuclear ProteinsRUNX1 protein, humanBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Biological Sciences, Superior University Lahore, Sargodha, Punjab, Pakistan.
  • Department of Zoology, University of Lahore, Sargodha, Punjab, Pakistan.
  • Department of Pathology, College of Medicine, Taif University, Taif, Saudi Arabia.

ORCID-Profile: Kashif Bashir

Förderung

  • The authors received no specific funding for this work.

Zitieren

APA

Bashir, K., Ghafar, S. A., Rehman, A. T., Waris, T., Farooq, F., & Alamin, A. A. (2025). Molecular Analysis of Genes CEBPA, NPM1 , IDH1 , and RUNX1 Polymorphisms as Biomarker Potential in Leukemia Patients. Molecular Carcinogenesis, 64(2), 357-368. https://doi.org/10.1002/mc.23846

Vancouver

Bashir K, Ghafar SA, Rehman AT, Waris T, Farooq F, Alamin AA. Molecular Analysis of Genes CEBPA, NPM1 , IDH1 , and RUNX1 Polymorphisms as Biomarker Potential in Leukemia Patients. Molecular Carcinogenesis. 2025;64(2):357-368. doi:10.1002/mc.23846

BibTeX
@article{Bashir2025,
  author = {Bashir, Kashif and Ghafar, Sadia Abdul and Rehman, Afifa Tur and Waris, Tayyaba and Farooq, Fatima and Alamin, Amin A},
  title = {Molecular Analysis of Genes CEBPA, NPM1 , IDH1 , and RUNX1 Polymorphisms as Biomarker Potential in Leukemia Patients},
  journal = {Molecular Carcinogenesis},
  year = {2025},
  volume = {64},
  number = {2},
  pages = {357--368},
  doi = {10.1002/mc.23846}
}
Kostenlos starten →